Effect of Spironolactone and Cyproterone Acetate on Breast Growth in Transgender People: A Randomized Clinical Trial
Antiandrogen choice should be based on clinician and patient preference with consideration of side effects. Further research is needed to optimize breast development in transgender people.
Authors
- James C.G. Doery (ORCID: https://orcid.org/0000-0002-1235-9913)
- Jeffrey D. Zajac (ORCID: https://orcid.org/0000-0003-3933-5708)
- Anna Kasielska‐Trojan (ORCID: https://orcid.org/0000-0002-2542-8623)
- Ada S. Cheung (ORCID: https://orcid.org/0000-0001-5257-5525)
- Maksym Mikołajczyk (ORCID: https://orcid.org/0000-0001-9828-6526)
- Lachlan M. Angus (ORCID: https://orcid.org/0000-0002-5842-6173)
- Shalem Leemaqz (ORCID: https://orcid.org/0000-0003-4616-8426)
Institutions
- The University of Melbourne (AU)
- Flinders University (AU)
- Aesthetic Surgery Center (US)
- Monash Health (AU)
- Medical University of Lodz (PL)
- Austin Health (AU)
- Monash University (AU)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1210/clinem/dgae650
- Citations
- 9
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 5.79